At EVQLV, we use epitope prediction to facilitate antibody engineering and design. See how we use cutting edge AI models to create super-multidimensional signatures of a protein. Creating digital signatures facilitates the engineering of therapeutic proteins and offers valuable insights into antibody targeting.